SELE and breast cancer: We found that tumor spheroid/aggregate grown MDA-MB-231 breast cancer cells upregulate their number of E-selectin ligands and binding moieties and demonstrated the most robust rolling behavior on E-selectin coated surfaces, compared to MDA-MB-231 cells from plasma and cytokine treatments, suggesting that CTMs may efficiently escape the bloodstream via a metastatic adhesion cascade.